| Literature DB >> 23201570 |
Hong Li1, Matthew L Edin, Artiom Gruzdev, Jennifer Cheng, J Alyce Bradbury, Joan P Graves, Laura M DeGraff, Darryl C Zeldin.
Abstract
Cyclooxygenases and their metabolites are important regulators of inflammatory responses and play critical roles in regulating the differentiation of T helper cell subsets in inflammatory diseases. In this review, we highlight new information on regulation of T helper cell subsets by cyclooxygenases and their metabolites. Prostanoids influence cytokine production by both antigen presenting cells and T cells to regulate the differentiation of naïve CD4(+) T cells to Th1, Th2 and Th17 cell phenotypes. Cyclooxygenases and PGE2 generally exacerbate Th2 and Th17 phenotypes, while suppressing Th1 differentiation. Thus, cycloxygenases may play a critical role in diseases that involve immune cell dysfunction. Targeting of cyclooxygenases and their eicosanoid products may represent a new approach for treatment of inflammatory diseases, tumors and autoimmune disorders. Published by Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23201570 PMCID: PMC3620713 DOI: 10.1016/j.prostaglandins.2012.11.002
Source DB: PubMed Journal: Prostaglandins Other Lipid Mediat ISSN: 1098-8823 Impact factor: 3.072